The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Open accessAbstract
Glioblastoma (GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF (also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low-grade disease that classically possesses PDGF and TP53 events. Here we show that concomitant central nervous system (CNS)-specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute-onset high-grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells (NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/progenitor cell differentiation, self-renewal and tumorigenic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although TP53 mutations are oncogenic in GBM, other genes, such as PTEN must also be mutated to drive GBM progression [28].”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, the chronic cellular damage that leads to liver cirrhosis results in shortened telomeres, anaphase bridges and a dramatically increased risk of liver cancer (131-134).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Self-citationErratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,435
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Self-citationClarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citationMultiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–759 of 759
microRNA-19b regulates proliferation & patterning in the avian forebrainPreprint
Mishra, A., Sindhu, S. K., Udaykumar, N., & Sen, J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.21.163980
PNO1 promotes human cholangiocarcinoma tumorigenesis and chemosensitivityPreprint
Chen, C., HUANG, S. H., Wu, G., Wang, Z., Lin, D.-Y., He, J., Li, K., Han, Z., Chen, X., Qiu, W., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-147851/v1
Self-citationThe Dynamic m6A Epitranscriptome in Glioma Stem Cell Plasticity and Function
Karambizi, D. I., & Tapinos, N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96792
Heng, H., Ing, Z. D., Rennan, C. B., & Hin, L. C. (2008)
The Effect of Chemotherapy on Stromal Components of the Bone Marrow
Hare, I. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5764
p53 supplementation as a targeted cancer gene therapy for glioblastoma
Sukumar, U. K., Massoud, T. F., & Paulmurugan, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00013-0
A Customisable Cell Line Model of Glioblastoma
Forsythe, D. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16632625.v1
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416570-0.00043-3
Perez, G. J., Fuentes-Fayos, A. C., Garcia-Garcia, M. E., Peel, A., Blanco, A. C., Solivera, J., Ibanez, C. A., Gahete, O. M., Castano, J. P., & Luque, R. M. (2022) · Endocrine Abstracts · doi:10.1530/endoabs.81.p132
Pediatric Glioblastoma Therapies Based on Patient-Derived Stem Cell Resources
Paddison, P. J. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada622192
Verma, R., Chen, X., Xin, D. E., Luo, Z., Ogurek, S., Xin, M., Rao, R., Berry, K., & Lu, Q. R. (2023) · doi:10.1158/0008-5472.c.6514394.v1
Verma, R., Chen, X., Xin, D. E., Luo, Z., Ogurek, S., Xin, M., Rao, R., Berry, K., & Lu, Q. R. (2023) · doi:10.1158/0008-5472.c.6514394
Ernst, A., Hofmann, S., Ahmadi, R., Becker, N., Korshunov, A., Engel, F., Hartmann, C. J., Felsberg, J., Sabel, M., Peterziel, H., et al. (2023) · doi:10.1158/1078-0432.c.6517587.v1
Klingler, S., Guo, B., Yao, J. P., Yan, H., Zhang, L., Vaseva, A. V., Chen, S., Canoll, P., Horner, J. W., Wang, Y., et al. (2023) · doi:10.1158/0008-5472.22406043
Self-citationWang, Q., Jia, S., Wang, D., Chen, X., Kalvakolanu, D. V., Zheng, H., Wei, X., Wen, N., Liang, H., Guo, B., et al. (2023) · doi:10.1158/1535-7163.c.6541920
Self-citationWang, Q., Jia, S., Wang, D., Chen, X., Kalvakolanu, D. V., Zheng, H., Wei, X., Wen, N., Liang, H., Guo, B., et al. (2023) · doi:10.1158/1535-7163.c.6541920.v1
Self-citationHill, K. S., Roberts, E. R., Wang, X., Marin, E. M., Park, T. D., Son, S., Ren, Y., Fang, B., Yoder, S., Kim, S., et al. (2023) · doi:10.1158/1541-7786.22515324
Hill, K. S., Roberts, E. R., Wang, X., Marin, E. M., Park, T. D., Son, S., Ren, Y., Fang, B., Yoder, S., Kim, S., et al. (2023) · doi:10.1158/1541-7786.22515324.v1
Genovese, G., Ergün, A., Shukla, S. A., Campos, B., Hanna, J. A., Ghosh, P., Quayle, S. N., Rai, K., Colla, S., Ying, H., et al. (2023) · doi:10.1158/2159-8290.22529354
Self-citationA Review on Cancer, Cause of Cancer and Treatment: Role of PIK3 Pathway on Cancer
Choudhary, M. L., & Sisodia, S. S. (2023) · Bioequivalence & Bioavailability International Journal · doi:10.23880/beba-16000208
Quaking Gene Expression as a Prognostic Marker in Neural Inflammation Disorders
Rostami, M., Mirarab, A., & Mohebbi, A. (2022) · Yādgār. · doi:10.61186/jcbr.6.2.1
Gómez, S. V., Garro, J. M. M., Ortiz, L. D., Flórez, J. E. S., Monroy, F. P., & Sánchez, R. G. P. (2024) · Biomedicines · doi:10.3390/biomedicines12102287
Exploring the dual role of nitric oxide in glioblastoma
Navasardyan, I., & Bonavida, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22354-9.00007-3
Molecular drivers in primary brain tumor formation
Richard, H. (2025) · Advances in cancer research · doi:10.1016/bs.acr.2025.04.006
microRNA-19b regulates proliferation & patterning in the avian forebrainPreprint
Mishra, A., Sindhu, S. K., Udaykumar, N., & Sen, J. (2025) · eLife · doi:10.7554/elife.105787
microRNA-19b regulates proliferation & patterning in the avian forebrainPreprint
Mishra, A., Sindhu, S. K., Udaykumar, N., & Sen, J. (2025) · eLife · doi:10.7554/elife.105787.1
The Current State of Gliomagenesis Knowledge in Light of New Classifications
Sgarbanti, L., Armocida, D., & Paglia, F. (2025) · Springer eBooks · doi:10.1007/978-3-031-81850-9_2
PTEN Defect Facilitates Neuronal Cell Differentiation via ERK5 ActivationPreprint
Dong, W., Fang, N., An, Y., & Ji, S. (2025) · Research Square · doi:10.21203/rs.3.rs-6905743/v1
Shneyderman, A., Hammer, S. S., Remmel, H. L., Veviorskiy, A., Alawi, K. M., Ustiugova, A. S., Korzinkin, M., Zhavoronkov, A. A., & Quay, S. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-22034-x
Pan, T., Yuan, L., Zhao, R., Lu, L., Zhi, Y., Li, Y., Wu, M., & Huang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70044
Wołodkiewicz, P., Juszczak, M., Tokarz, P., Woźniak, K., & Tokarz, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-22754-0
Mehta, I. S. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Stemness status in differentiated and undifferentiated glioma cells
Khan, Z. (2011) · CLOK (University of Central Lancashire)
Additional file 1 of MiR-4310 induced by SP1 targets PTEN to promote glioma progression
Wu, Z., Luo, J., Huang, T., Yi, R., Ding, S., Xie, C., Xu, A., Zeng, Y., Wang, X., Song, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466799
Trivieri, N., Visioli, A., Mencarelli, G., Cariglia, M. G., Marongiu, L., Pracella, R., Giani, F., Soriano, A. A., Barile, C., Cajola, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19586926
Trivieri, N., Visioli, A., Mencarelli, G., Cariglia, M. G., Marongiu, L., Pracella, R., Giani, F., Soriano, A. A., Barile, C., Cajola, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19586932
Additional file 2 of MiR-4310 induced by SP1 targets PTEN to promote glioma progression
Wu, Z., Luo, J., Huang, T., Yi, R., Ding, S., Xie, C., Xu, A., Zeng, Y., Wang, X., Song, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466805
Additional file 3 of MiR-4310 induced by SP1 targets PTEN to promote glioma progression
Wu, Z., Luo, J., Huang, T., Yi, R., Ding, S., Xie, C., Xu, A., Zeng, Y., Wang, X., Song, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466801
PI3-kinase, Akt, mTOR, and treatment
Rosen, D. B., Huynh, M. A., & Haas-Kogan, D. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27356-8.00017-6
Modulation of hippo pathway by alternative splicing
Srivastava, D. (2019) · theses.fr (ABES) · doi:10.70675/39639c36z8ae3z4f14z9907zaaead2a13436
Glioblastoma resistance to temozolomide : implication of α5β1 integrin and p53 signalling pathways
Sani, S. (2020) · theses.fr (ABES) · doi:10.70675/9566c585z0508z455bz9064z6bb61435b210
Characterization of cellular heterogeneity in Diffuse Low Grade Glioma
Augustus, M. (2020) · theses.fr (ABES) · doi:10.70675/037c23a4z44ddz4bb7z999ezb0c178c35170
Migration of neural stem cells during human neocortical development
Wimmer, R. (2024) · theses.fr (ABES) · doi:10.70675/2c5a181cz0cdaz4afdza39bz5e5cb0197aef
Xu, L., Li, F., Wen, N., Wu, C., Zhu, A., Hou, Y., Wang, W., Zhao, Y., Zheng, H., & Zhang, L. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112569
Self-citationYang, M., Chen, X., Li, M., Yang, J., Zheng, H., Shi, S., Luo, Q., Liang, Y., Xu, L., Kalvakolanu, D. V., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118197
Self-citationIntegrated profiling identifies NCOA3 as a prognostic factor in patients with glioma
Luo, Q., Yang, J., 尹海林, Yang, M., Liang, Y., Hou, Y., Sun, X., Liu, J., & Zhang, L. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-02007-7
mTOR-Mediated Neuron–Cancer Interactions
Nyarkoh, J. K., Wolan, M. J., & Feliciano, D. M. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4030024
Architects of Aggression: The Molecular Blueprint of Glioma Progression
Aebisher, D., Tylutki, J., Myśliwiec, A., Kozak, N., & Bartusik‐Aebisher, D. (2026) · Genes · doi:10.3390/genes17091120
Nishimura, R. N., & Gera, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198743
Targeting NOTCH-immune crosstalk in gliomas: from mechanisms to therapeutics
Ebrahimi, S., Meshkinkhood, N., Aliee, A., Yuhan, L., Koulivand, M., Koulivand, Z., & Gorji, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1936605
Neurodevelopmental Blueprint in Gliomas: Toward an Ontogenetic Multimodal Integrated Therapy
Padevit, L., Weiß, T., Vasella, F., Neidert, M. C., Serra, C., Krayenbühl, N., Zadeh, G. M., Weller, M., Regli, L., & Akeret, K. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-25-02798
Tumor Associated Neutrophils Extend NETs To Spatially Drive Necroptosis In GlioblastomaPreprint
Vaddi, P. K., Zhuang, Y., Liu, L., Ingersoll, S., Lee, S., Gao, B., van Bokhoven, A., Harris, B. T., Pine, S. R., & Sabaawy, H. E. (2026) · medRxiv · doi:10.64898/2026.10.25.26366446
Investigating tumour evolution through graph theoretical analysis of gene regulatory networks
Upton, A. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Liu, K.-W. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Cheerathodi, M., & McCarty, J. H. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1431-5_7
Metadata
- Authors
- Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., Stommel, J. M., Dunn, K. L., Wiedemeyer, R., You, M. J., Brennan, C., Wang, Y. A., Ligon, K. L., Wong, W. H., Chin, L., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Stanford University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2008-10
- Volume
- 455
- Issue
- 7216
- Pages
- 1129-1133
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4051433
- OpenAlex
- W2109610561
- Cited by
- 767
- References
- 37
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 32 · 2023: 41 · 2022: 33 · 2021: 32 · 2020: 41 · 2019: 33 · 2018: 35 · 2017: 38 · 2016: 39 · 2015: 46 · 2014: 47 · 2013: 61 · 2012: 76
- FWCI
- 27.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (R01 CA99041, R01CA099041, U01CA84313, 5P01CA95616, U01CA084313, P01CA095616)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- p53, PTEN, glioblastoma, neural stem cells, glioma stem cells, c-Myc, tumor suppressor inactivation, cell differentiation, cell renewal, TP53 mutation, PTEN mutation, gene expression profiling, promoter analysis, EGFR, neurofibromatosis type 1, RB1, ATM, APC
- MeSH terms
- Animals, Brain Neoplasms, Cell Differentiation, Gene Expression Regulation, Glioblastoma, Glioma, Humans, Immunohistochemistry, Neurons, Neoplastic Stem Cells, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
